APO Research
Talk to an analyst

APO RESEARCH · REPORT

Synthetic Opioids

Compare research editions
View pricing & licenses

Selected research

Industry Research

Synthetic Opioids Industry Research Report 2026

20 December 2025124 pages

Choose your research edition.

Industry ResearchSynthetic Opioids Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Synthetic Opioids Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Synthetic Opioids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Synthetic Opioids Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Synthetic Opioids Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Synthetic Opioids market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Synthetic Opioids is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Synthetic Opioids is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Synthetic Opioids include Endo International, Impax Laboratories, Indivior, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Purdue Pharma, West-Ward Pharmaceuticals, Pfizer and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Synthetic Opioids market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Synthetic Opioids Market by Company

Endo International

Impax Laboratories

Indivior

Janssen Pharmaceuticals

Mallinckrodt Pharmaceuticals

Purdue Pharma

West-Ward Pharmaceuticals

Pfizer

Mylan

Teva Pharmaceuticals

Synthetic Opioids Segment by Type

Hydrocodone

Oxymorphone

Oxycodone

Meperidine

Methadone

Fentanyl

Synthetic Opioids Segment by Application

Pain Management

De-addiction

Synthetic Opioids Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Opioids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synthetic Opioids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Opioids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Synthetic Opioids manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Synthetic Opioids by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Synthetic Opioids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Synthetic Opioids Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Synthetic Opioids Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Synthetic Opioids Sales Market Share by Manufacturers (2021-2026) Table 8. Global Synthetic Opioids Revenue of Manufacturers (2021-2026) Table 9. Global Synthetic Opioids Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Synthetic Opioids Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Synthetic Opioids Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Synthetic Opioids, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Synthetic Opioids, Product Type & Application Table 14. Global Synthetic Opioids Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Synthetic Opioids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Endo International Company Information Table 19. Endo International Business Overview Table 20. Endo International Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Endo International Synthetic Opioids Product Portfolio Table 22. Endo International Recent Developments Table 23. Impax Laboratories Company Information Table 24. Impax Laboratories Business Overview Table 25. Impax Laboratories Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Impax Laboratories Synthetic Opioids Product Portfolio Table 27. Impax Laboratories Recent Developments Table 28. Indivior Company Information Table 29. Indivior Business Overview Table 30. Indivior Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Indivior Synthetic Opioids Product Portfolio Table 32. Indivior Recent Developments Table 33. Janssen Pharmaceuticals Company Information Table 34. Janssen Pharmaceuticals Business Overview Table 35. Janssen Pharmaceuticals Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Janssen Pharmaceuticals Synthetic Opioids Product Portfolio Table 37. Janssen Pharmaceuticals Recent Developments Table 38. Mallinckrodt Pharmaceuticals Company Information Table 39. Mallinckrodt Pharmaceuticals Business Overview Table 40. Mallinckrodt Pharmaceuticals Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Mallinckrodt Pharmaceuticals Synthetic Opioids Product Portfolio Table 42. Mallinckrodt Pharmaceuticals Recent Developments Table 43. Purdue Pharma Company Information Table 44. Purdue Pharma Business Overview Table 45. Purdue Pharma Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Purdue Pharma Synthetic Opioids Product Portfolio Table 47. Purdue Pharma Recent Developments Table 48. West-Ward Pharmaceuticals Company Information Table 49. West-Ward Pharmaceuticals Business Overview Table 50. West-Ward Pharmaceuticals Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. West-Ward Pharmaceuticals Synthetic Opioids Product Portfolio Table 52. West-Ward Pharmaceuticals Recent Developments Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Pfizer Synthetic Opioids Product Portfolio Table 57. Pfizer Recent Developments Table 58. Mylan Company Information Table 59. Mylan Business Overview Table 60. Mylan Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Mylan Synthetic Opioids Product Portfolio Table 62. Mylan Recent Developments Table 63. Teva Pharmaceuticals Company Information Table 64. Teva Pharmaceuticals Business Overview Table 65. Teva Pharmaceuticals Synthetic Opioids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceuticals Synthetic Opioids Product Portfolio Table 67. Teva Pharmaceuticals Recent Developments Table 68. Global Synthetic Opioids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Synthetic Opioids Sales by Region (2021-2026) & (K Units) Table 70. Global Synthetic Opioids Sales Market Share by Region (2021-2026) Table 71. Global Synthetic Opioids Sales by Region (2027-2032) & (K Units) Table 72. Global Synthetic Opioids Sales Market Share by Region (2027-2032) Table 73. Global Synthetic Opioids Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Synthetic Opioids Revenue Market Share by Region (2021-2026) Table 75. Global Synthetic Opioids Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Synthetic Opioids Revenue Market Share by Region (2027-2032) Table 77. North America Synthetic Opioids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 79. North America Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 80. North America Synthetic Opioids Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Synthetic Opioids Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Synthetic Opioids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 84. Europe Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 85. Europe Synthetic Opioids Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Synthetic Opioids Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Synthetic Opioids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 89. Asia Pacific Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 90. Asia Pacific Synthetic Opioids Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Synthetic Opioids Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Synthetic Opioids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 94. South America Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 95. South America Synthetic Opioids Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Synthetic Opioids Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Synthetic Opioids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 99. Middle East and Africa Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 100. Middle East and Africa Synthetic Opioids Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Synthetic Opioids Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Synthetic Opioids Sales by Type (2021-2026) & (K Units) Table 103. Global Synthetic Opioids Sales by Type (2027-2032) & (K Units) Table 104. Global Synthetic Opioids Sales Market Share by Type (2021-2026) Table 105. Global Synthetic Opioids Sales Market Share by Type (2027-2032) Table 106. Global Synthetic Opioids Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Synthetic Opioids Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Synthetic Opioids Revenue Market Share by Type (2021-2026) Table 109. Global Synthetic Opioids Revenue Market Share by Type (2027-2032) Table 110. Global Synthetic Opioids Price by Type (2021-2026) & (US$/Unit) Table 111. Global Synthetic Opioids Price by Type (2027-2032) & (US$/Unit) Table 112. Global Synthetic Opioids Sales by Application (2021-2026) & (K Units) Table 113. Global Synthetic Opioids Sales by Application (2027-2032) & (K Units) Table 114. Global Synthetic Opioids Sales Market Share by Application (2021-2026) Table 115. Global Synthetic Opioids Sales Market Share by Application (2027-2032) Table 116. Global Synthetic Opioids Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Synthetic Opioids Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Synthetic Opioids Revenue Market Share by Application (2021-2026) Table 119. Global Synthetic Opioids Revenue Market Share by Application (2027-2032) Table 120. Global Synthetic Opioids Price by Application (2021-2026) & (US$/Unit) Table 121. Global Synthetic Opioids Price by Application (2027-2032) & (US$/Unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Synthetic Opioids Distributors List Table 125. Synthetic Opioids Customers List Table 126. Synthetic Opioids Industry Trends Table 127. Synthetic Opioids Industry Drivers Table 128. Synthetic Opioids Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Synthetic Opioids Product Image Figure 5. Global Synthetic Opioids Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Synthetic Opioids Market Size (2021-2032) & (US$ Million) Figure 7. Global Synthetic Opioids Sales (2021-2032) & (K Units) Figure 8. Global Synthetic Opioids Average Price (US$/Unit) & (2021-2032) Figure 9. Hydrocodone Product Image Figure 10. Oxymorphone Product Image Figure 11. Oxycodone Product Image Figure 12. Meperidine Product Image Figure 13. Methadone Product Image Figure 14. Fentanyl Product Image Figure 15. Pain Management Product Image Figure 16. De-addiction Product Image Figure 17. Global Synthetic Opioids Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Synthetic Opioids, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Synthetic Opioids Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Synthetic Opioids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Synthetic Opioids Sales by Region in 2025 Figure 23. Global Synthetic Opioids Revenue by Region in 2025 Figure 24. North America Synthetic Opioids Market Size by Country in 2025 Figure 25. North America Synthetic Opioids Sales Market Share by Country (2021-2032) Figure 26. North America Synthetic Opioids Revenue Market Share by Country (2021-2032) Figure 27. United States Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Synthetic Opioids Market Size by Country in 2025 Figure 30. Europe Synthetic Opioids Sales Market Share by Country (2021-2032) Figure 31. Europe Synthetic Opioids Revenue Market Share by Country (2021-2032) Figure 32. Germany Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Nordic Countries Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Asia Pacific Synthetic Opioids Market Size by Country in 2025 Figure 39. Asia Pacific Synthetic Opioids Sales Market Share by Country (2021-2032) Figure 40. Asia Pacific Synthetic Opioids Revenue Market Share by Country (2021-2032) Figure 41. China Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Japan Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. South Korea Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. India Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Australia Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. China Taiwan Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South America Synthetic Opioids Market Size by Country in 2025 Figure 50. South America Synthetic Opioids Sales Market Share by Country (2021-2032) Figure 51. South America Synthetic Opioids Revenue Market Share by Country (2021-2032) Figure 52. Mexico Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Brazil Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Colombia Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Synthetic Opioids Market Size by Country in 2025 Figure 57. Middle East and Africa Synthetic Opioids Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Synthetic Opioids Revenue Market Share by Country (2021-2032) Figure 59. Turkey Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Synthetic Opioids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Synthetic Opioids Sales Market Share by Type (2021-2032) Figure 63. Global Synthetic Opioids Revenue Market Share by Type (2021-2032) Figure 64. Global Synthetic Opioids Price (US$/Unit) by Type (2021-2032) Figure 65. Global Synthetic Opioids Sales Market Share by Application (2021-2032) Figure 66. Global Synthetic Opioids Revenue Market Share by Application (2021-2032) Figure 67. Global Synthetic Opioids Price (US$/Unit) by Application (2021-2032) Figure 68. Synthetic Opioids Value Chain Figure 69. Synthetic Opioids Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Synthetic Opioids Industry Opportunities and Challenges

Scope & coverage.

Types
  • Hydrocodone
  • Oxymorphone
  • Oxycodone
  • Meperidine
  • Methadone
  • Fentanyl
Applications
  • Pain Management
  • De-addiction
Companies covered
  • Endo International
  • Impax Laboratories
  • Indivior
  • Janssen Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
  • Purdue Pharma
  • West-Ward Pharmaceuticals
  • Pfizer
  • Mylan
  • Teva Pharmaceuticals

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Synthetic Opioids Market Size (2021-2032)
  4. 2.2.2 Global Synthetic Opioids Sales (2021-2032)
  5. 2.2.3 Global Synthetic Opioids Market Average Price (2021-2032)
  6. 2.3 Synthetic Opioids by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Hydrocodone
  9. 2.3.3 Oxymorphone
  10. 2.3.4 Oxycodone
  11. 2.3.5 Meperidine
  12. 2.3.6 Methadone
  13. 2.3.7 Fentanyl
  14. 2.4 Synthetic Opioids by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Pain Management
  17. 2.4.3 De-addiction
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Synthetic Opioids Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Synthetic Opioids Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Synthetic Opioids Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Synthetic Opioids Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Synthetic Opioids Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Synthetic Opioids, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Synthetic Opioids, Product Type & Application
  8. 3.8 Global Manufacturers of Synthetic Opioids, Established Date
  9. 3.9 Global Synthetic Opioids Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Endo International
  2. 4.1.1 Endo International Company Information
  3. 4.1.2 Endo International Business Overview
  4. 4.1.3 Endo International Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Endo International Synthetic Opioids Product Portfolio
  6. 4.1.5 Endo International Recent Developments
  7. 4.2 Impax Laboratories
  8. 4.2.1 Impax Laboratories Company Information
  9. 4.2.2 Impax Laboratories Business Overview
  10. 4.2.3 Impax Laboratories Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Impax Laboratories Synthetic Opioids Product Portfolio
  12. 4.2.5 Impax Laboratories Recent Developments
  13. 4.3 Indivior
  14. 4.3.1 Indivior Company Information
  15. 4.3.2 Indivior Business Overview
  16. 4.3.3 Indivior Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Indivior Synthetic Opioids Product Portfolio
  18. 4.3.5 Indivior Recent Developments
  19. 4.4 Janssen Pharmaceuticals
  20. 4.4.1 Janssen Pharmaceuticals Company Information
  21. 4.4.2 Janssen Pharmaceuticals Business Overview
  22. 4.4.3 Janssen Pharmaceuticals Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Janssen Pharmaceuticals Synthetic Opioids Product Portfolio
  24. 4.4.5 Janssen Pharmaceuticals Recent Developments
  25. 4.5 Mallinckrodt Pharmaceuticals
  26. 4.5.1 Mallinckrodt Pharmaceuticals Company Information
  27. 4.5.2 Mallinckrodt Pharmaceuticals Business Overview
  28. 4.5.3 Mallinckrodt Pharmaceuticals Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Mallinckrodt Pharmaceuticals Synthetic Opioids Product Portfolio
  30. 4.5.5 Mallinckrodt Pharmaceuticals Recent Developments
  31. 4.6 Purdue Pharma
  32. 4.6.1 Purdue Pharma Company Information
  33. 4.6.2 Purdue Pharma Business Overview
  34. 4.6.3 Purdue Pharma Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Purdue Pharma Synthetic Opioids Product Portfolio
  36. 4.6.5 Purdue Pharma Recent Developments
  37. 4.7 West-Ward Pharmaceuticals
  38. 4.7.1 West-Ward Pharmaceuticals Company Information
  39. 4.7.2 West-Ward Pharmaceuticals Business Overview
  40. 4.7.3 West-Ward Pharmaceuticals Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 West-Ward Pharmaceuticals Synthetic Opioids Product Portfolio
  42. 4.7.5 West-Ward Pharmaceuticals Recent Developments
  43. 4.8 Pfizer
  44. 4.8.1 Pfizer Company Information
  45. 4.8.2 Pfizer Business Overview
  46. 4.8.3 Pfizer Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pfizer Synthetic Opioids Product Portfolio
  48. 4.8.5 Pfizer Recent Developments
  49. 4.9 Mylan
  50. 4.9.1 Mylan Company Information
  51. 4.9.2 Mylan Business Overview
  52. 4.9.3 Mylan Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mylan Synthetic Opioids Product Portfolio
  54. 4.9.5 Mylan Recent Developments
  55. 4.10 Teva Pharmaceuticals
  56. 4.10.1 Teva Pharmaceuticals Company Information
  57. 4.10.2 Teva Pharmaceuticals Business Overview
  58. 4.10.3 Teva Pharmaceuticals Synthetic Opioids Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Teva Pharmaceuticals Synthetic Opioids Product Portfolio
  60. 4.10.5 Teva Pharmaceuticals Recent Developments
5 Global Synthetic Opioids Market Scenario by Region
  1. 5.1 Global Synthetic Opioids Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Synthetic Opioids Sales by Region: 2021-2032
  3. 5.2.1 Global Synthetic Opioids Sales by Region: 2021-2026
  4. 5.2.2 Global Synthetic Opioids Sales by Region: 2027-2032
  5. 5.3 Global Synthetic Opioids Revenue by Region: 2021-2032
  6. 5.3.1 Global Synthetic Opioids Revenue by Region: 2021-2026
  7. 5.3.2 Global Synthetic Opioids Revenue by Region: 2027-2032
  8. 5.4 North America Synthetic Opioids Market Facts & Figures by Country
  9. 5.4.1 North America Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Synthetic Opioids Sales by Country (2021-2032)
  11. 5.4.3 North America Synthetic Opioids Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Synthetic Opioids Market Facts & Figures by Country
  15. 5.5.1 Europe Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Synthetic Opioids Sales by Country (2021-2032)
  17. 5.5.3 Europe Synthetic Opioids Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Synthetic Opioids Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Synthetic Opioids Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Synthetic Opioids Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Synthetic Opioids Market Facts & Figures by Country
  36. 5.7.1 South America Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Synthetic Opioids Sales by Country (2021-2032)
  38. 5.7.3 South America Synthetic Opioids Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.7.7 Colombia
  43. 5.8 Middle East and Africa Synthetic Opioids Market Facts & Figures by Country
  44. 5.8.1 Middle East and Africa Synthetic Opioids Market Size by Country: 2021 VS 2025 VS 2032
  45. 5.8.2 Middle East and Africa Synthetic Opioids Sales by Country (2021-2032)
  46. 5.8.3 Middle East and Africa Synthetic Opioids Revenue by Country (2021-2032)
  47. 5.8.4 Turkey
  48. 5.8.5 Saudi Arabia
  49. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Synthetic Opioids Sales by Type (2021-2032)
  2. 6.1.1 Global Synthetic Opioids Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Synthetic Opioids Sales Market Share by Type (2021-2032)
  4. 6.2 Global Synthetic Opioids Revenue by Type (2021-2032)
  5. 6.2.1 Global Synthetic Opioids Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Synthetic Opioids Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Synthetic Opioids Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Synthetic Opioids Sales by Application (2021-2032)
  2. 7.1.1 Global Synthetic Opioids Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Synthetic Opioids Sales Market Share by Application (2021-2032)
  4. 7.2 Global Synthetic Opioids Revenue by Application (2021-2032)
  5. 7.2.1 Global Synthetic Opioids Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Synthetic Opioids Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Synthetic Opioids Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Synthetic Opioids Value Chain Analysis
  2. 8.1.1 Synthetic Opioids Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Synthetic Opioids Production Mode & Process
  5. 8.2 Synthetic Opioids Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Synthetic Opioids Distributors
  8. 8.2.3 Synthetic Opioids Customers
9 Global Synthetic Opioids Analyzing Market Dynamics
  1. 9.1 Synthetic Opioids Industry Trends
  2. 9.2 Synthetic Opioids Industry Drivers
  3. 9.3 Synthetic Opioids Industry Opportunities and Challenges
  4. 9.4 Synthetic Opioids Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst